ACEL Financial Facts

Interest expense, related party: -6.95K
Net Income (Loss) per common share - Diluted: -0.03
See Full Income Statement

Prepaid expenses and other current assets: 45.11K
Accrued interest, convertible debt: 0
See Full Balance Sheet

Tamir Biotechnology, Inc. (ACEL) Earnings

  |   Expand Research on ACEL
Next EPS Date 11/10/26 EPS Growth Rate +6.3%
Average EPS % Beat Rate -31.4% Revenue Growth Rate +8.2%
Average % Move 1-Wk after EPS -3.3% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/10/26 Q326 N/A$0.17 N/A N/A$356.75M N/A N/A N/A
8/4/26 Q226 $0.15$0.20 -$0.05$368.13M$355.6M N/A Details
5/5/26 Q126 $0.17$0.20 -$0.03$352M$341.74M N/A Details
3/3/26 Q425 $0.00N/A N/A $341.45M$335.27M N/A Details
11/4/25 Q325 $0.16$0.21 -$0.05$329.7M$327.95M N/A Details
8/5/25 Q225 $0.08$0.21 -$0.13$335.9M$328.85M N/A Details
5/5/25 Q125 $0.17$0.24 -$0.07$323.9M$310.34M N/A Details
2/27/25 Q424 N/A$0.20 N/A N/A$304.11M N/A N/A N/A